Making Medicines Better™

MERRION PHARMACEUTICALS Announces Participation at the 14th Annual Drug Delivery Partnerships, Orlando, Florida. Presentation Wednesday 27th January 2010 'Partnering in Oral Drug Delivery of Therapeutic Polypeptides for the Treatment of Diabetes- the Novo Nordisk A/S- Merrion Collaboration'

At Merrion Pharmaceuticals our team of researchers and professionals invest their skills and energy in developing new medicines that will make a difference to International health care. We are inventing distinctly different and new medicinal products, which provide a clear patient benefit, as well as meeting an unmet medical need. For example.

Make oral versions of previously injectable only medicines, offers the following benefits:

Superior convenience of administration to patients (such as being able to take your medicine at home instead of attending a hospital or clinic)
Avoid injection site complications (e.g. infections)
More flexible dosing options
Improved tolerance and fewer dosing options
Allowing new patient populations to benefit from drugs
Better drug efficacy (helping the drug to work better)